In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Type 2 diabetes has become increasingly pervasive, driven by the complex interplay between genetic predisposition and modern ...

In addition to working for the police, the Company carries out forensic analysis and case review for the defence and provides ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

Companies, 23andMe included, also have a responsibility to notify consumers of changes and get "consumers' affirmative ...

Lin said he went through two or three iterations of testing nearly 100 potential solutions before he found one that could be ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...